Real-World Data Improves Early Detection
A recent study showed using real-world blood pressure (BP) measurements to identify pediatric patients at risk of hypertension-related diseases in adulthood could potentially optimize patient care and help save on costs.
Mark Mitsnefes, MD, MS, director of the Clinical and Translational Research Center at Cincinnati Children’s, was one of the authors of the multi-center study published in the December 2023 issue of eBioMedicine.
“We know that accurate diagnosis of hypertension in childhood is important, since, if untreated it can lead to cardiovascular and kidney problems in adulthood, like myocardial infarction, stroke and kidney failure. But the way we currently identify hypertension in pediatric patients is based on normative data compiled from research and relatively small studies largely conducted decades ago,” Mitsnefes says.
To see if normative values could be created from real-world data, Mitsnefes and a team of researchers from eight large health systems gathered the electronic health records (EHR) of more than 8 million children—derived from the health systems and aggregated by PEDSnet, a multi-institutional pediatric health system network—and filtered them to narrow the sample size.
The study’s participating health systems included:
- Cincinnati Children’s
- Children’s Hospital Colorado
- Children’s Hospital of Philadelphia
- Lurie Children’s Hospital of Chicago
- Nationwide Children’s Hospital
- Nemours Children’s Health
- Seattle Children’s Hospital
- Stanford Medicine Children’s Health
Children between the ages of 3 and 17 years with a body mass index (BMI) lower than the 85th percentile were included. Around 1 million BP measurements from nearly 300,000 children were analyzed. This is a significantly larger sample size than the current database of normative BP values, which was compiled from roughly 60,000 to 70,000 measurements taken from around 50,000 pediatric patients between the 1970s and 1990s.